glp 1 cancer GLP-1 weight-loss drugs are transforming lives — but what do they really mean for people facing cancer? We brought together perspectives from researchers, clinicians and patients navigating the promise and the tradeoffs More Good News for GLP-1

The FDA has approved GLP-1 and related medications for chronic weight management in adults with obesity or adults with overweight and at least one weight-related condition, when used along with reduced-calorie nutrition and increased physical activity

Adv Sci 9(15):e2103222

It is not medical advice.

(FDA Compounding Memorandum, 2023 [ Australia (TGA): BPC-157 is not approved by the TGA

Regenerative priming: Brief BPC-157 exposure may reprogramme cellular responses (e.g., activating quiescent fibroblast populations) in a way that persists after peptide clearance

The 15 mg starter vial is $80 with a $39 medical visit fee